← Back to Search

Control condition with "waiting for you" message for COVID-19

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days after receiving the sms/mms intervention
Awards & highlights

Study Summary

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination by communicating to patients that they live in an area with significant COVID transmission and a control message telling patients that an updated COVID booster vaccine is waiting for them.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days after receiving the sms/mms intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days after receiving the sms/mms intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Patient uptake of COVID bivalent booster

Trial Design

2Treatment groups
Experimental Treatment
Group I: Message communicating latest data on COVID transmission in patient's areaExperimental Treatment1 Intervention
This condition will use a text message informing the participant of the latest data on COVID transmission in participant's area and recommend a COVID vaccination.
Group II: Control condition with "waiting for you" messageExperimental Treatment1 Intervention
This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID Booster text messages
2022
N/A
~4980000

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,360,088 Total Patients Enrolled
32 Trials studying COVID-19
5,754,017 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor accepting new participants at the moment?

"All evidence on clinicaltrials.gov points to this trial no longer actively recruiting patients, with the initial post date being November 3rd 2022 and their last update taking place on November 16th 2022. Although there are no current recruitment openings, 1032 other medical trials currently have available spots for interested candidates."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Message Communicating Latest Data on COVID-19 Transmission in Patient's Area
2022. "Message Communicating Latest Data on COVID-19 Transmission in Patient's Area". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05621226.
~215172 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top